Effect of Metabolic Modulation on a Post-acute COVID-19 Vaccination Syndrome (PACVS) Cohort

Launched by INDEPENDENT MEDICAL ALLIANCE · May 5, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at whether a special nutritional supplement, called ViTAL SCAN, can help adults who have been experiencing ongoing fatigue and other symptoms after receiving a Covid-19 vaccine. This condition, known as post-acute Covid-19 vaccination syndrome (PACVS), can leave people feeling very tired and unable to exercise, and it has been confirmed by lab tests. The researchers want to find out if taking this supplement can improve patients' quality of life and help with certain health markers related to metabolism and inflammation.

To participate in this study, individuals must be at least 18 years old, have had persistent fatigue for more than six months after getting a Covid-19 vaccine, and have specific lab results showing signs of the vaccine's impact on their body. Participants will take the supplement or a placebo (a harmless powder) daily for three months, attend clinic visits for tests, and answer questions about their health and lifestyle. The study is not yet recruiting, but it aims to enroll 100 adults to see if the supplement can make a difference in their symptoms and overall well-being.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Persistent fatigue lasting more than 6 months
• • Received at least one dose of a Covid-19 vaccine, after which they experienced fatigue symptoms (symptom onset within two weeks of vaccination)
• • Laboratory result showing persistent spike protein in blood OR presence of spike protein antibodies with SARS-CoV-2 nucleocapsid antibodies negative.
• Exclusion Criteria:
• • Pregnant
• • History of Schizophrenia
• • Currently using antidepressant medication